Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tenofovir resistance and resensitization.

Antimicrobial agents and chemotherapy - 1 Nov 2003

Wolf Katharina, Walter Hauke, Beerenwinkel Niko, Keulen Wilco, Kaiser Rolf, Hoffmann Daniel, Lengauer Thomas, Selbig Joachim, Vandamme Anne-Mieke, Korn Klaus, Schmidt Barbara

Abstract excerpt

Human immunodeficiency viruses in 321 samples from tenofovir-naïve patients were retrospectively evaluated for resistance to this nucleotide analogue. All virus strains with insertions between amino acids 67 and 70 of the reverse transcriptase (n = 6) were highly resistant. Virus strains with the Q151M mutation were divided into susceptible (n = 12) and highly resistant (n = 8) viruses. This difference was due to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenine
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Reverse Transcriptase

Share to Organophosphonates

Share to Organophosphorus Compounds

Share to Reverse Transcriptase Inhibitors

Share to Tenofovir

Share to Thymidine

Source

Open in PubMed Open full text

Identifiers

PMID: 14576105
DOI: 10.1128/AAC.47.11.3478-3484.2003
PMCID: PMC253768

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tenofovir resistance and resensitization.PMID 14576105Read ↗

K65R, TAMs and tenofovir.Semantic proximity Read ↗

Mutations at 65 and 70 within the context of a Q151M cluster in human immunodeficiency virus type 1 reverse transcriptase impact the susceptibility to the different nucleoside reverse transcriptase inhibitors in distinct ways.Semantic proximity Read ↗

Broad Nucleoside Reverse‐Transcriptase Inhibitor Cross‐Resistance in Human Immunodeficiency Virus Type 1 Clinical IsolatesSemantic proximity Read ↗

UPDATE ON DRUG RESISTANCE MUTATIONS IN HIV-1Semantic proximity Read ↗

Genotypic HIV-1 Drug Resistance Among Patients Failing Tenofovir-Based First-Line HAART in South India.Semantic proximity Read ↗

Resistance of human immunodeficiency virus type 1 to a third-generation fusion inhibitor requires multiple mutations in gp41 and is accompanied by a dramatic loss of gp41 function.Semantic proximity Read ↗

Clonal resistance analyses of HIV type-1 after failure of therapy with didanosine, lamivudine and tenofovir.Semantic proximity Read ↗

A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance.Semantic proximity Read ↗

International cohort analysis of the antiviral activities of zidovudine and tenofovir in the presence of the K65R mutation in reverse transcriptase.Semantic proximity Read ↗

Novel drug resistance pattern associated with the mutations K70G and M184V in human immunodeficiency virus type 1 reverse transcriptase.Semantic proximity Read ↗

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.Semantic proximity Read ↗

Changing patterns in HIV reverse transcriptase resistance mutations after availability of tenofovir.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.